Get started
Author

Jacob McGee

Observed names: J McGee, J. McGee, J. Mcgee, Jacob D. McGee, Jacob Mcgee
Observed institutions: Western University, Dalhousie University, Sunnybrook Health Science Centre, University Health Network, University of British Columbia, University of Toronto, London Health Sciences Centre, Women's College Hospital, Princess Margaret Cancer Centre, Victoria Hospital, Nova Scotia Cancer Centre, Centre Hospitalier de l’Université de Montréal, Institute for Clinical Evaluative Sciences, Sunnybrook Hospital, Canadian Cancer Trials Group, Odette Cancer Centre, University of Manitoba, Université de Montréal, McMaster University
ORCID: 0000-0003-3210-0682
Observed ORCID: 0000-0003-3210-0682
OpenAlex ID: A5046028077
Enhanced recovery after surgery: implementing a new standard of surgical care
2019 · Alon D. Altman, Limor Helpman, et al. · Canadian Medical Association Journal · 164
PDF
TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids
2015 · Samah Rafehi, Yudith Ramos Valdes, et al. · Endocrine Related Cancer · 92
PDF
Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability
2014 · Rohann J.M. Correa, Yudith Ramos Valdes, et al. · Carcinogenesis · 72
PDF
Teaching surgery takes time: the impact of surgical education on time in the operating room
2016 · Christopher Vinden, Richard Malthaner, et al. · Canadian Journal of Surgery · 71
PDF
Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids
2015 · Teresa Peart, Yudith Ramos Valdes, et al. · Oncotarget · 66
PDF
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors
2017 · J. McGee, M. Bookman, et al. · Annals of Oncology · 65
PDF
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
2017 · Jacob McGee, Vasily Giannakeas, et al. · Gynecologic Oncology · 41
Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study
2017 · Alon D. Altman, Jacob McGee, et al. · Gynecologic Oncology · 34
Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment
2010 · Helen J. Mackay, Jacob McGee, et al. · Journal of Clinical Virology · 34
Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer
2018 · Taymaa May, Alon Altman, et al. · International Journal of Gynecological Cancer · 31
High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma
2016 · Kitty Huang, David D'Souza, et al. · Brachytherapy · 28
Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario
2017 · Jacob McGee, Karen Panabaker, et al. · International Journal of Gynecological Cancer · 24
PDF
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts
2024 · Laura Bravo, Joana FF Simões, et al. · The Lancet Digital Health · 22
Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data
2021 · Manjusha Hurry, Shazia Hassan, et al. · Journal of health economics and outcomes research · 20
PDF
Genetic and epigenetic profiling of BRCA1/2 in ovarian tumors reveals additive diagnostic yield and evidence of a genomic BRCA1/2 DNA methylation signature
2020 · Erfan Aref-Eshghi, Jacob D. McGee, et al. · Journal of Human Genetics · 19
PDF
A Population-Based Assessment of Urologic Procedures and Operations After Surgery or Pelvic Radiation for Cervical Cancer
2018 · Blayne Welk, Christopher Wallis, et al. · International Journal of Gynecological Cancer · 18
Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The “Opt-Out” Process
2019 · Jacob McGee, Teresa M. Peart, et al. · Journal of Oncology · 15
PDF
Treatment Tolerance and Side Effects of Intraperitoneal Carboplatin and Dose-Dense Intravenous Paclitaxel in Ovarian Cancer
2018 · Steven P. Bisch, Akira Sugimoto, et al. · Journal of Obstetrics and Gynaecology Canada · 15
Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
2016 · Vikram Velker, David D’Souza, et al. · International Journal of Gynecological Cancer · 15
Resident Trainees Increase Surgical Time: A Comparison of Obstetric and Gynaecologic Procedures in Academic Versus Community Hospitals
2019 · Jacob McGee, Jennifer Winick-Ng, et al. · Journal of Obstetrics and Gynaecology Canada · 13
Hysterectomy in Ontario: A Population-Based Study of Outcomes and Complications in Minimally Invasive Compared with Abdominal Approaches
2019 · Erin C. Kelly, Jennifer Winick-Ng, et al. · Journal of Obstetrics and Gynaecology Canada · 13
Understanding Characteristics, Treatment Patterns, and Clinical Outcomes for Individuals with Advanced or Recurrent Endometrial Cancer in Alberta, Canada: A Retrospective, Population-Based Cohort Study
2023 · Diana Martins, Dylan E. O’Sullivan, et al. · Current Oncology · 9
PDF
Anthropometric Measures and Risk of Ovarian Cancer Among BRCA1 and BRCA2 Mutation Carriers
2012 · Jacob McGee, Joanne Kotsopoulos, et al. · Obesity · 9
PDF
Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian Cancer
2024 · Gordon Taylor Moffat, Weidong Kong, et al. · Gynecologic Oncology · 7
PDF
Complication Rates after Endometrial Ablation in Ontario: A Cohort Analysis of 76 446 Patients
2021 · Sara Ilnitsky, Andrew McClure, et al. · Journal of Minimally Invasive Gynecology · 7
Works count: 67
Citation count: 945
H-index: 16
I10-index: 21
Year
Topic
Type